BridgeMD
EFFICACY OF INFILTRATED MEPIVACAINE AS A LOCAL ANESTHETIC PRIOR TO ARTERIAL PUNCTURE: A RANDOMIZED CONTROLLED CLINICAL TRIAL
EU CTIS ID: 2025-522974-35-00
What this study is testing
To evaluate the efficacy of infiltrated mepivacaine versus placebo and nothing to reduce pain caused by arterial puncture during blood gas analysis in patients at the Pneumology Outpatient Department.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- - Adults 18≥80 years; Present a good level of consciousness (Glasgow scale score >15); To have signed the Informed Consent Form.
You likely can't join if
- Have a medical condition or difficulty communicating due to psychological disorders, dementia, speech impairment or language barrier; Obtain a Glasgow scale score <15; Being under the effect of alcohol, central nervous system depressant substances or active treatment for pain with opiates; Pregnant or lactating women; Patients whose pathological situation may interfere with the development of the study (e.g. clinical/psychological involvement, trauma to both wrists...); Patients with allergy or previous adverse reactions to amides; Obtaining an abnormal result in the Allen test; Decreased peripheral sensitivity of extremities due to any disease, such as diabetes; Raynaud's phenomenon; Previous participation in the same clinical trial; Inability to give Informed Consent; Do not accept to participate in the study after having been informed verbally and with documentation.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.